Cancer mortality in patients with schizophrenia: Systematic review and meta-analysis

British Journal of Psychiatry

Volumn 211, Issue 1, 2017, Pages 7-13

  Zhuo, Chuanjun ^a,b   Tao, Ran ^c   Jiang, Ronghuan ^c   Lin, Xiaodong ^a   Shao, Mingjing ^d  

^a Wenzhou Seventh People's Hospital   (China)

^b Tianjin Anding Hospital   (China)

^c People's Liberation Army   (China)

^d Chinese People's Liberation Army Postgraduate Medical School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE ASSOCIATION; HUMAN; MENTAL PATIENT; MORTALITY RISK; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; COMPLICATION; META ANALYSIS; MORTALITY; NEOPLASM;

HUMANS; NEOPLASMS; SCHIZOPHRENIA;

EID: 85021817620     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.116.195776     Document Type: Review

References (54)

1. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016; 388: 86-97.
2. Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat 2016; 12: 357-73.
3. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005; 66: 1122-9.
4. Cloutier M, Aigbogun MS, Guerin A, Nitulescu R, Ramanakumar AV, Kamat SA, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry 2016; 77: 764-71.
5. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-31.
6. Bushe CJ, Taylor M, Haukka J. Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol 2010; 24: 17-25.
7. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol 2014; 10: 425-48.
8. Chou FH, Tsai KY, Wu HC, Shen SP. Cancer in patients with schizophrenia: what is the next step? Psychiatry Clin Neurosci 2016; 70: 473-88.
9. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72: 1172-81.
10. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010; 196: 116-21.
11. Reininghaus U, Dutta R, Dazzan P, Doody GA, Fearon P, Lappin J, et al. Mortality in schizophrenia and other psychoses: a 10-year follow-up of the SOP first-episode cohort. Schizophr Bull 2015; 41: 664-73.
12. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis, JAMA Psychiatry 2015; 72: 334-41.
13. Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170: 324-33.
14. Mortensen PB, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand 1990; 81: 372-7.
15. Saku M, Tokudome S, Ikeda M, Kono S, Makimoto K, uchimura H, et al. Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol 1995; 24: 366-72.
16. Lawrence D, Holman CD, Jablensky AV, Threlfall TJ, Fuller SA. Excess cancer mortality in western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr scand 2000; 101: 382-8.
17. Laursen TM, Munk-Oisen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007; 68: 899-907.
18. Castagnini A, Foldager L, Bertelsen A. Excess mortality of acute and transient psychotic disorders: Comparison with bipolar affective disorder and schizophrenia. Acta Psychiatr Scand 2013; 128: 370-5.
19. Heila H, Haukka J, Suvisaari J, Lonnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005; 35: 725-32
20. Tran E, Rouillon F, Loze JY, casadebaig F, Philippe A, Vitry F, et al. Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer 2009; 115: 3555-62.
21. Daumit GL, Anthony CB, Ford DE, Fahey M, Skinner EA, Lehman AF, et al. Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res 2010; 176: 242-5.
22. Talaslahti T, Alanen HM, Hakko H, Isohanni M, Hakkinen U, Leinonen E. Mortality and causes of death in older patients with schizophrenia, int J Geriatr Psychiatry 2012; 27: 1131-7.
23. Guan NC, Termorshuizen F, Laan w, smeets HM, zainal NZ, Kahn RS, et al. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1289-95.
24. Kisely S, Crowe E, Lawrence D. cancer-related mortality in people with mental illness. JAMA Psychiatry 2013; 70: 209-17.
25. Almeida OP, Hankey GJ, Yeap BB, Golledge J, Norman PE. Flicker L. Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37, 892 men. PloS One 2014; 9: e111882.
26. Kredentser MS, Martens PJ, Chochinov HM, Prior HJ. cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. J Clin Psychiatry 2014; 75: 154-61.
27. Kisely S, Forsyth S, Lawrence D. Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? Aust NZJ Psychiatry 2016; 50: 254-63.
28. Hodgson R, Wildgust HJ, Bushe CJ. Cancer and schizophrenia: is there a paradox? J Psychopharmacol 2010; 24: 51-60.
29. Bushe CJ, Hodgson R. Schizophrenia and cancer: in 2010 do we understand the connection? Can J Psychiatry 2010; 55: 761-7.
30. Catala-Lopez F, Suarez-Pinilla M, Suarez-Pinilla P, Valderas JM, Gomez-Beneyto M, Martinez S, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577, 013 participants of 50 observational studies. Psychother Psychosom 2014; 83: 89-105.
31. Dalton SO, Laursen TM, Mellemkjaer L, Johansen c, Mortensen PB. Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry 2004; 161: 903-8.
32. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 2000; 283: 2008-12.
33. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-7.
34. Grigoletti L, Perini G, Rossi A, Biggeri A, Barbui C, Tansella M, et al. Mortality and cause of death among psychiatric patients: a 20-year case-register study in an area with a community-based system of care. Psychol Med 2009; 39: 1875-84.
35. Perini G, Grigoletti L, Hanife B, Biggeri A, Tansella M, Amaddeo F. cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study. Soc Psychiatry Psychiatr Epidemiol 2014; 49: 693-701.
36. Batty GD, Whitley E, Gale CR, Osborn D, Tynelius P, Rasmussen F. Impact of mental health problems on case fatality in male cancer patients. Br J cancer 2012; 106: 1842-5.
37. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
38. Altman DG, Bland JM. How to obtain the confidence interval from a P value. BM/2011; 343: d2090.
39. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
40. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test, BMJ 1997; 315: 629-34.
41. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163: 183-9.
42. Chou FH, Tsai KY, Su CY, Lee CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 2011; 129: 97-103.
43. Bergamo C, Sigel K, Mhango G, Kale M, Wisnivesky JP. inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosom Med 2014; 76: 215-20.
44. Beary M, Hodgson R, Wildgust HJ. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol 2012; 26: 52-61.
45. Cunningham R, Sarfati D, Stanley J, Peterson D, Collings S. Cancer survival in the context of mental illness: a national cohort study. Gen Hosp Psychiatry 2015; 37: 501-6.
46. Mitchell AJ, Pereira IE, Yadegarfar M, Pepereke S, Mugadza V, Stubbs B. Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake. Br J Psychiatry 2014; 205: 428-35.
47. Stubbs B, Koyanagi A, Veronese N, Vancampfort D, Solmi M, Gaughran F, et al. Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242, 952 people across 48 low-and middle-income countries. BMC Med 2016; 14: 189.
48. Mitchell AJ, Vancampfort D, De Hert M, Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. Gen Hosp Psychiatry 2015; 37: 14-23.
49. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374: 620-7.
50. De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, et al. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 2016; 133: 5-22.
51. Froes Brandao D, Strasser-Weippl K, Goss PE. Prolactin and breast cancer: the need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: a review. Cancer 2016; 122: 184-8.
52. De Hert M, Vancampfort D, Stubbs B, Sabbe T, Wildiers H, Detraux J. Antipsychotic treatment, prolactin, and breast tumorigenesis. Psychiatr Danub 2016; 28: 243-54.
53. Jones ME, Swerdlow AJ. Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol 1998; 148: 1012-7.
54. Card TR, Solaymani-Dodaran M, Hubbard R, Logan RF, west J. is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health 2006; 60: 819-21.